Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Verinurad Tablets in Healthy Males
NCT02336594Phase 1Completed
- Sponsor
- Ardea Biosciences, Inc.
- Start
- Nov 2014
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of verinurad in gout (4 arms), sponsored by Ardea Biosciences, Inc. Primary endpoints: Maximum Observed Plasma Concentration, Time of Occurrence of Maximum Observed Concentration and 3 more. Started Nov 2014; status: completed.
02
Drugs
verinurad
03
Conditions
gout
Beyond the preview
Go deeper on NCT02336594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02336594.